Expression, purification and crystallization of a collagen-binding fragment of Yersinia adhesin YadA.

Acta Crystallogr D Biol Crystallogr

Structural Biology and Biophysics, Institute of Biotechnology, University of Helsinki, Viikinkaari 1, PO Box 65, FIN-00014 University of Helsinki, Finland.

Published: June 2002

A recombinant form of a collagen-binding fragment of Yersinia enterocolitica serotype O:3 adhesin YadA with an N-terminal polyhistidine affinity tag has been produced in Escherichia coli, purified and crystallized using the sitting-drop vapour-diffusion technique. Crystals belong to the trigonal space group R3, with unit-cell parameters a = b = 67.05, c = 221.95 A, and diffract to 1.55 A resolution on a synchrotron-radiation source.

Download full-text PDF

Source
http://dx.doi.org/10.1107/s0907444902005231DOI Listing

Publication Analysis

Top Keywords

collagen-binding fragment
8
fragment yersinia
8
adhesin yada
8
expression purification
4
purification crystallization
4
crystallization collagen-binding
4
yersinia adhesin
4
yada recombinant
4
recombinant form
4
form collagen-binding
4

Similar Publications

Multifunctional polymeric nanocapsules with enhanced cartilage penetration and retention for osteoarthritis treatment.

J Control Release

October 2024

State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, Sichuan, China. Electronic address:

Osteoarthritis (OA) is a prevalent joint disease characterized by cartilage degeneration and subchondral bone homeostasis imbalance. Effective topical OA therapy is challenging, as therapeutic drugs often suffer from insufficient penetration and rapid clearance. We develop miniature polydopamine (PDA) nanocapsules (sub-60 nm), which are conjugated with collagen-binding polypeptide (CBP) and loaded with an anabolic drug (i.

View Article and Find Full Text PDF

The Versatility of Collagen in Pharmacology: Targeting Collagen, Targeting with Collagen.

Int J Mol Sci

June 2024

Mitochondrial and Molecular Medicine Research Group, Facultad de Medicina y Ciencias de la Salud, Universidad Católica de Valencia San Vicente Mártir, 46001 Valencia, Spain.

Collagen, a versatile family of proteins with 28 members and 44 genes, is pivotal in maintaining tissue integrity and function. It plays a crucial role in physiological processes like wound healing, hemostasis, and pathological conditions such as fibrosis and cancer. Collagen is a target in these processes.

View Article and Find Full Text PDF

From Collagen Mimetics to Collagen Hybridization and Back.

Acc Chem Res

June 2024

Department of Molecular Pharmaceutics, University of Utah, Salt Lake City, Utah 84112, United States.

ConspectusFacilitated by the unique triple-helical protein structure, fibrous collagens, the principal proteins in animals, demonstrate a dual function of serving as building blocks for tissue scaffolds and as a bioactive material capable of swift renewal in response to environmental changes. While studies of triple-helical collagen mimetic peptides (CMPs) have been instrumental in understanding the molecular forces responsible for the folding and assembly of triple helices, as well as identifying bioactive regions of fibrous collagen molecules, single-strand CMPs that can specifically target and hybridize to denatured collagens (i.e.

View Article and Find Full Text PDF

To develop peptide drugs targeting integrin receptors, synthetic peptide ligands endowed with well-defined selective binding motifs are necessary. The snake venom KTS-containing disintegrins, which selectively block collagen α1β1 integrin, were used as lead compounds for the synthesis and structure-activity relationship of a series of linear peptides containing the KTS-pharmacophore and alternating natural amino acids and 3-aminobenzoic acid (MABA). To ensure a better stiffness and metabolic stability, one, two and three MABA residues, were introduced around the KTS pharmacophore motif.

View Article and Find Full Text PDF
Article Synopsis
  • - Necrotic enteritis in poultry is caused by the bacterium Clostridium perfringens, and researchers developed nanobodies that can bind and neutralize key toxins produced by this bacterium.
  • - A total of six effective nanobodies were identified, showing high activity against these toxins and stability in chicken gastrointestinal fluids, and they were expressed using two different microbial systems (Pichia pastoris and Bacillus subtilis).
  • - When chickens were fed with these nanobodies incorporated either in supernatants or as spores, mortality rates significantly decreased, highlighting the potential for using nanobody technology to better control necrotic enteritis in poultry.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!